2. FUNCTIONS
ā¢ IN CASES OF NON UNIONS
ā¢ AS A FILLER AFTER EXCISIONS
ā¢ AS STRUCTURAL SUPPORT AS IN CASES OF PROX TIBIA FRACTURES
ā¢ TO ENHANCE FRACTURE HEALING
ā¢ IN OSTEOPOROTIC FRACTURES
ā¢ PREVENTING POST OP COLLAPSES
3. MECHANISM
ā¢ ACTS BY MAINLY 3 PROPERTIES
1. Osteoconduction
ā¢ Provides matrix for bone growth
2.Osteoinduction
ā¢ Growth factors encourage mesenchymal cells to differentiate into
osteoblastic lineages thereby osteogenesis is induced
3.Osteogenesis
ā¢ Transplanted osteoblasts and periosteal cells directly produce
bone
4. TYPES
ā¢ Autograft
ā¢ Allograft
ā¢ Bone graft substitutes
ā¢ Most have osteoconductive properties
ā¢ Osteoinductive agents
ā¢ rhBMP-2 (Infuse) and rhBMP-7 (OP-1)
5. AUTOGENOUS
ā¢ āGold standardā
ā¢ May provide osteoconduction, osteoinduction and osteogenesis
ā¢ Drawbacks
ā¢ Limited supply
ā¢ Donor site morbidity like risk of infection
7. CANCELLOUS
ā¢ Three dimensional scaffold (osteoconductive)
ā¢ Osteocytes and stem cells (osteogenic)
ā¢ A small quantity of growth factors (osteoinductive)
ā¢ Little initial structural support
ā¢ Can gain support quickly as bone is formed
8. CORTICAL
ā¢ Less biologically active than cancellous bone
ā¢ Less porous, less surface area, less cellular matrix
ā¢ Prologed time to revascularizarion
ā¢ Provides more structural support
ā¢ Can be used to span defects
ā¢ Vascularized cortical grafts
ā¢ Better structural support due to earlier incorporation
ā¢ Also osteogenic, osteoinductive
ā¢ Transported periosteum
9. BONE MARROW ASPIRATE
ā¢ Osteogenic
ā¢ Mesenchymal stem cells (osteoprogenitor cells) exist in a 1:50,000
ratio to nucleated cells in marrow aspirate
ā¢ Numbers decrease with advancing age
ā¢ Can be used in combination with an osteoconductive matrix
10. AUTOGRAFT HARVEST
ā¢ Cancellous
ā¢ Iliac crest (most common)
ā¢ Anterior- taken from gluteus medius pillar
ā¢ Posterior- taken from posterior ilium near SI joint
ā¢ Metaphyseal bone
ā¢ May offer local source for graft harvest
ā¢ Greater trochanter, distal femur, proximal or distal tibia,
calcaneus, olecranon, distal radius, proximal humerus
11. AUTOGRAFT HARVEST
ā¢ Cancellous harvest technique
ā¢ Cortical window made with osteotomes
ā¢ Cancellous bone harvested with gouge or currette
ā¢ Can be done with trephine instrument
ā¢ Circular drills
ā¢ Commercially available trephines or āharvestersā
ā¢ Can be a percutaneus procedure
12. AUTOGRAFT HARVEST
ā¢ Cortical
ā¢ Fibula common donor
ā¢ Avoid distal fibula to protect ankle function
ā¢ Preserve head to keep LCL, hamstrings intact
ā¢ Iliac crest
ā¢ Cortical or tricortical pieces can be harvested in shape to fill
defect
13. BONE ALLOGRAFTS
ā¢ Cancellous or cortical
ā¢ Plentiful supply
ā¢ Limited infection risk (varies based on processing method)
ā¢ Provide osteoconductive scaffold
ā¢ May provide structural support
14. BONE ALLOGRAFTS
ā¢ Available in various forms
ā¢ Processing methods may vary between companies / agencies
ā¢ Fresh
ā¢ Fresh Frozen
ā¢ Freeze Dried
15. BONE ALLOGRAFTS
ā¢ Fresh
ā¢ Highly antigenic
ā¢ Limited time to test for immunogenicity or diseases
ā¢ Use limited to joint replacement using shape matched
osteochondral allografts
Fresh frozen
ā¢ Less antigenic
ā¢ Time to test for diseases
ā¢ Preserves biomechanical properties
ā¢ Good for structural grafts
16. ā¢ Freeze-dried
ā¢ Even less antigenic
ā¢ Time to test for diseases
ā¢ Can be stored at room temperature up to 5 years
ā¢ Mechanical properties degrade
17. GRAFT INCORPORATION
ā¢ Hematoma formation
ā¢ Release of cytokines and growth factors
ā¢ Inflammation
ā¢ Development of fibrovascular tissue
ā¢ Vascular ingrowth
ā¢ Often extending Haversian canals
ā¢ Focal osteoclastic resorption of graft
ā¢ Intramembranous and/or endochondral bone formation on graft
surfaces
18.
19. BONE GRAFT SUBSTITUTES
ā¢ Need for bone graft alternatives has lead to development of
numerous bone graft substitutes
ā¢ Avoid morbidity of autogenous bone graft harvest
ā¢ Mechanical properties vary
ā¢ Most offer osteoconductive properties
ā¢ Some provide osteoinductive properties
20. ā¢ Extender for autogenous bone graft
ā¢ Large defects
ā¢ Multiple level spinal fusion
ā¢ Enhancer
ā¢ To improve success of autogenous bone graft
ā¢ Substitute
ā¢ To replace autogenous bone graft
21. BONE GRAFT SUBSTITUTES
ā¢ Calcium phosphate
ā¢ Calcium sulfate
ā¢ Collagen based matrices
ā¢ Demineralized bone matrix
ā¢ Hydroxyapatite
ā¢ Tricalcium phosphate
ā¢ Osteoinductive proteins
22. ā¢ Resorption rates vary widely
ā¢ Dependant on composition
ā¢ Calcium sulfate - very rapid
ā¢ Hydroxyapatite (HA) ā very, very slow
ā¢ Mechanical properties vary widely
ā¢ Dependant on composition
ā¢ Calcium phosphate cement has highest compressive strength
ā¢ Cancellous bone compressive strength is relatively low
ā¢ Many substitutes have compressive strengths similar to
cancellous bone
ā¢ All designed to be used with internal fixation
23. CALCIUM PHSOPHATE
ā¢Injectable pastes of calcium and
phospate
ā¢ Norian SRS (Synthes/Stratec)
ā¢ Alpha BSM (Etex/Depuy)
ā¢ Injectable
ā¢ Very high compressive strength
once hardens
ā¢ Some studies of its use have
allowed earlier weightbearing
and range of motion
24. CALCIUM SULPHATE
ļ· Osteoconductive void filler
ļ· Low compressive strength ā no structural support
ļ· Rapidly resorbs
ļ· May be used as a autogenous graft extender
- Available from numerous companies
- stimulan, Osteoset, Calceon 6, Bone Blast, etc.
ā¢ Pellets
ā¢ Pellet injectors
ā¢ Bead kits
ā¢ Allows addition of antibiotics
ā¢ Injectable
ā¢ May be used to augment screw purchase
25. COLLAGEN BASED MATRICES
ā¢ Highly purified Type 1 bovine
dermal fibrillar collagen
ā¢ Bone marrow is added to
provide bone forming cells
ā¢ Collagraft (Zimmer)
ā¢ Collagen / HA / Tricalcium
phosphate
ā¢ Healos (Depuy)
ā¢ Collagen / HA
26. DEMINERALISED BONE MATRIX
ā¢ Prepared from cadaveric human bone
ā¢ Acid extraction of bone leaving
ā¢ Collagen
ā¢ Noncollagenous proteins
ā¢ Bone growth factors
ā¢ BMP quantity extremely low and variable
ā¢ Sterilized which may decrease the availability of BMP
ā¢ Available from multiple vendors in multiple preparations
ā¢ Gel
ā¢ Putty
ā¢ Strip
ā¢ Combination products with cancellous bone and other bone graft substitute products
27. ā¢ Growth factor activity varies
between tissue banks and
between batches
ā¢ While they may offer some
osteoinductive potential
because of available growth
factors, they mainly act as an
osteoconductive agents
28. HYDROXYAPATITE
ā¢ Produced from marine coral exoskeletons that are
hydrothermically converted to hydroxyapatite, the
natural mineral composition of bone
ā¢ Interconnected porous structure closely resembles
the porosity of human cancellous bone
ā¢ Available in various size blocks & granules
ā¢ G bone by Surgiwear
CORALLINE HYDROXYAPATITE
CANCELLOUS BONE
29. TRICALCIUM PHOSPHATE
ā¢ Wet compressive strength
slightly less than cancellous
bone
ā¢ Available as blocks, wedges, and
granules
30. BONE MORPHOGENETIC PROTEINS
ā¢ Produced by recombinant technology
ā¢ Two most extensively studied and commercially available
ā¢ BMP-2 (Infuse) Medtronics
ā¢ BMP-7 (OP-1) Stryker Biotech
31. INDICATIONS FOR BONE GRAFTING
ā¢Provide mechanical support
ā¢ Metaphyseal impaction
ā¢Replace bone
ā¢ Cortical or segmental defect
ā¢Stimulate healing
ā¢ Nonunions
ā¢ Arthrodesis